Raza Bokhari's guest appearances

Raza Bokhari

Stock Day Media

The Exchange for Entrepreneurs™ Podcast 

Chris Bunka

Paul Pedersen

Evan Gappelberg

Brad Moore

Rana Vig

Tommy Chong

Omar Khan

Jonathan Herman

Frank Holmes

Jonathan Awde

Greg James

Todd Davis

Timothy Sykes

Greg Hahn

Matt Goldman

OwlTail

CSE’s Barrington Miller was recently joined in the studio by Dr. Raza Bokhari, CEO of FSD Pharma (CSE:HUGE), whose company recently celebrated their market open at the Canadian Securities Exchange. In this discussion Dr. Bokhari shares what it’s like to be the first company to be dual-listed on the CSE and NASDAQ (1:35), the importance for companies in the capital markets to be in “the big ocean” (5:25), the groundbreaking clinical trials FSD Pharma is conducting with a synthetic compound that acts like CBD (6:30), and the “HUGE” importance of their ticker symbol (11:00).Listen until the end to hear Dr. Bokhari’s personal path towards becoming a serial, “eccentric”, entrepreneur (12:30).

CSE’s Barrington Miller was recently joined in the studio by Dr. Raza Bokhari, CEO of FSD Pharma (CSE:HUGE), whose company recently celebrated their market open at the Canadian Securities Exchange.  In this discussion Dr. Bokhari shares what it’s like to be the first company to be dual-listed on the CSE and NASDAQ (1:35), the importance for companies in the capital markets to be in “the big ocean” (5:25), the groundbreaking clinical trials FSD Pharma is conducting with a synthetic compound that acts like CBD (6:30), and the “HUGE” importance of their ticker symbol (11:00). Listen until the end to hear Dr. Bokhari’s personal path towards becoming a serial, “eccentric”, entrepreneur (12:30).

Dr. Raza Bokhari on the Real Promise of CBD | #HashtagFinance

The Stock Day Podcast welcomed FSD Pharma (HUGE)(“the Company”), a specialty biotech pharmaceutical R&amp;D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. CEO of the Company, Dr. Raza Bokhari, joined Stock Day host Everett Jolly.

FSD Pharma CEO, Dr. Raza Bokhari, Discusses 2020 Goals with The Stock Day Podcast